CLINICAL_TRIALS
trial_result
· 2016-10-26
Clinical Trial Update: Endometrial Receptivity After GnRH Agonist Triggering [Phase 4]
Summary
A Phase 4 clinical trial evaluating endometrial receptivity after GnRH agonist triggering has completed. The sponsor is IVI Madrid.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: IVI Madrid | Conditions: Ovarian Hyperstimulation Syndrome | Phase 4 | Status: COMPLETED